Introduction
three important goals are to delay progression, to prevent co-morbidity (cardiovascular complications Locatelli: There has been a striking increase in the and anaemia) and to prepare patients for RRT. incidence of end-stage renal disease ( ESRD) over the Cambi: Our main goal is to keep the patient's metabolic last 30 years world-wide [1] . The growing proportion state as near to normal as possible. This means checkof elderly patients mainly accounts for the total ing blood pressure, acid-base balance and nutrition, increase in the number of these patients admitted to waiting until these are satisfactory; ensuring correct renal replacement therapy ( RRT ), with a dramatically iron status and avoiding secondary hyperparathyroidhigh morbidity and mortality rate [1] [2] [3] .
ism. Anaemia will come later and at that point it A number of physiological and metabolic changes should be corrected. The majority of patients are old may contribute not only towards progressive loss of (the mean age of patients starting dialysis is 70 years) renal function but also to increased mortality observed and most of them do not need immediate dialysis thereafter, during the dialytic phase. The detection and treatment if metabolic conditions are stable. correction of these events may slow the progression of Hoenich: In the United Kingdom ( UK ) blood pressure chronic renal insufficiency (CRI ) and delay the need control, nutrition and acid-base control provide the for dialysis. Thus the question of whether therapeutic framework for pre-dialysis patient monitoring. interventions may retard the progression of CRI in Erythropoietin ( EPO) treatment is not widely used in man is extremely important not only clinically, but pre-dialysis patients due to its cost. also in terms of patient suffering and the social and Bommer: Effective antihypertensive therapy, timely economic impact of regular RRT [4] .
installation of vascular access, and appropriate start of dialysis are the targets in treating preuraemic patients.
Pre-dialysis-overall objectives
Locatelli: I would like to start the discussion of the Protein and calorie intake pre-dialysis phase by focusing on the overall objectives of treatment in this phase. Leunissen: To maintain kidney function for as long as Locatelli: I suggest we add the level of protein intake in the pre-dialysis diet to the discussion. In my opinion possible in the treatment of CRI and to prevent important co-morbidity (in particular cardiovascular a 'controlled protein diet' (that is a protein intake between 0.8 and 1 g/kg bw/day with a calorie intake morbidity) thus helping to improve the survival of the patient, both during dialysis treatment time and when no less than 30 Kcal/kg bw/day) should be used in 'normal' patients; in 'selected' patients you may try to a patient is transplanted. To treat CRI patients optimally, with regard not only to cardiovascular complica-reduce the protein intake according to the compliance of the patient. I wonder, however, if it is useful and tions but also in relation to nutritional status (most patients are already malnourished when they start safe to reduce the protein intake to less than 0.8 g/kg bw/day, considering the small advantage in slowing dialysis). Valderrábano: I am co-ordinating a Spanish document down the progression of the underlying disease towards ESRD and the need for dialysis, as well as the high risk of malnutrition [4] [5] [6] [7] .
Correspondence and offprint requests to: Prof. Dr Francesco Locatelli, intake [8] and at the patient's general condition, in Bommer: In the immediate pre-dialysis phase I suggest no protein or dietary restriction. Protein intake in the order to avoid malnutrition [9] (a point made in our pre-dialytic period decreases with the progression of multicentre trial on the effect of a low protein diet renal failure and in most patients a normal, free [5] ). The message was not to use a 'free diet' (as spontaneous protein intake is no more than 0.8 g/kg generally misquoted ) but a 'controlled protein diet' bw/day [10] . I am more concerned with malnutrition stressing above all the importance of 'general medical and feel that nutritional restriction could augment this care' on patient outcome.
[11]. In the rural population, more than in the urban Hoenich: I agree that protein intake should not be population, patients generally do not eat what has below 0.8 g/kg bw/day in view of the evidence that been recommended: they tend to eat what they like to very low protein intake may lead to a nitrogen defieat. Therefore, the food preferences of the individual ciency associated with increased mortality. However, patients should be respected in the dietary recomit may take considerable time and expense to reverse mendations. the hypoalbuminaemia and the cost benefit analysis Locatelli: A free protein intake should not be recomneeds to be assessed.
mended since patients reduce their protein intake sponBommer: The literature shows that patients with taneously without any knowledge of the importance advanced renal failure without dietary restriction eat of the different nutrients in their diet. Therefore dietary less than 1 g/kg bw/day [10] . Further restrictions are recommendations should be given to the patients, not indicated in preuraemic patients.
enabling them to choose different nutrients to improve Cambi: Patients with renal failure spontaneously eat their general well-being, reduce acidosis and avoid very low protein diets and that may lead to malnutrimalnutrition. tion [10] . If you suggest a free diet, they eat very little Leunissen: It is questionable whether one can overcome protein; so the paradox is the highest amount compatdecreased protein synthesis by eating more protein as ible with 500-600 mg phosphate per day.
there is a balance between protein synthesis and protein Locatelli: It seems to me there is a general consensus degradation. When a patients is acidotic, there is a that one should not reduce protein intake too much, decrease in essential short chain amino acids intracelluconsidering the problem of possible malnutrition of larly and it is impossible to increase this level by eating paramount importance [11, 12] . It is well known that more protein. malnutrition is an important factor affecting survival later on during dialysis [13, 14] .
We have reached consensus that it would be quite impossible and could also be dangerous to reduce Acid-base balance protein intake to less than 0.8 g/kg bw/day in the predialysis phase. I wonder if there is a role for a veget-Locatelli: What about the treatment of pre-dialysis arian diet as a substitution for animal proteins [12, 15] . acidosis? I am asking the panel to consider the level Cambi: I think that the issue is marginal. In my opinion of bicarbonate needed in order to correct acidosis. it is a mistake to give a target to the name (vegetarian Valderrábano: Acidosis increases protein breakdown diet, hypoproteic diet) and not to target the con-[17,18], decreases the content of some amino acids in sequences: acidosis, hyperkalaemia and hyperphos-muscle cells and promotes the liberation of calcium phataemia. A vegetarian diet lacks certain essential from bone. A patient with a creatinine clearance of nutrients, so is not complete. Many patients with 20-25 ml/min is generally symptomatic and has to be reduced appetite do not select proper food and become encouraged to increase protein intake because the malnourished. If they are below the minimum level of majority of these patients consider proteins to be protein, the type of protein that they could eat (soya, unhealthy. fish, egg) should be suggested.
Bommer: Giving a patient many tablets increases comHoenich: I agree with the protein level of 0.8 g/kg pliance problems. Phosphate binding and antihyperbw/day (except possibly in very old patients when it tensive treatment are more important than the may be too much) but a calorie intake of 35 Kcal/kg correction of acidosis. bw/day would be at the upper limit.
Leunissen: In The Netherlands, most nephrology Locatelli: I agree that the protein intake of the elderly centres do not correct acidosis adequately in the preshould be less than that of younger patients, particu-dialysis phase. larly when they are in good health.
Locatelli: I would like to remind you that one of the Leunissen: I agree with the importance of the relation-advantages of low protein diets is the correction of ship between calorie and protein intake. I think that acidosis. This was particularly important in earlier we should not only define an upper limit of calorie years (35 years ago) [19, 20] when the 'low protein diet' intake of 35 Kcal/kg bw/day, but also a lower limit, was introduced at a time when dialysis facilities were because when patients get less energy, they will become not easily available and it was possible to recover catabolic and acidotic [16 ] . Poor dialysis will decrease patients from uraemic coma. This type of coma was the appetite and many patients on a prescribed protein more often related to metabolic acidosis than to the intake of 0.8 g/kg bw/day cannot eat it because their retention of nitrogen metabolites. Thus, my suggestion is to normalise plasma bicarbonate levels completely, appetite is not good enough.
while also taking into account the increasingly reco-which kind of drugs are used [21] . The open question is if ACE inhibitors can slow down the progression of gnised importance of acidosis in protein breakdown. Cambi: By using calcium carbonate, only small CRI better than other antihypertensive drugs while providing the same level of perfect blood pressure amounts of sodium bicarbonate are needed, thus maintaining acid-base balance and patient tolerance.
control (120/80 mmHg). There are no data available in the literature. Thus, prospective controlled randomValderrábano: In Spain very few doctors give bicarbonate to pre-dialysis patients, mainly to those with ized trials are needed to clarify this important aspect.
However, I wonder if it is possible to reach the goal pyelonephritis.
Bommer: I suggest one should not raise plasma bicar-of blood pressure values of 120/80 mmHg in a control patient group which is not treated with ACE inhibitors bonate levels above 18-19 mEq/l. Locatelli: Thus, which seems strange to me, you don't or angiotensin II receptor antagonists, considering that in CRI patients one usually needs three or four drugs consider acidosis as an important clinical problem in pre-dialysis patients. Do you really consider that good to normalise blood pressure values. Moreover, the importance of the level of proteinuria as a marker of correction of metabolic acidosis is obtained at plasma bicarbonate levels of 18-19 mEq/l? I suggest, in agree-CRI progression is increasingly recognized and, above all, the importance of reducing proteinuria as an ment with the other panellists, one should aim to reach a plasma bicarbonate level of not less than 22 mEq/l. important tool for slowing down CRI progression even in normotensive patients [4, [27] [28] [29] . Thus, the goal is not only to look at blood pressure values but also at 
Anaemia correction
personal opinion in this very hot field? I ask you to consider the following two aspects of the problem, namely the target blood pressure to be achieved, par-Locatelli: I suggest we discuss in more detail the topic of pre-dialysis anaemia: its definition, the target haemticularly in proteinuric patients, and which particular drugs (such as ACE inhibitors and angiotensin II atocrit (Hct) and the role of iron supplements (per os or i.v.) per se and in relation to the use of EPO. receptor antagonists) should be used to further slow down CRI progression, possibly at lower levels of Leunissen: Because of reimbursement policies, EPO is only started after correcting iron status, although it blood pressure (i.e. 120/80 mmHg) than that of the trials designed to date (140/90 mmHg).
could be started earlier. I would like to emphasise the importance of investigating further the long-term effect Hoenich: Control of blood pressure is, to date, the only intervention other than the treatment of primary of a low Hct on left ventricular muscle mass. A study in the Netherlands is comparing this in three patient disease that has been demonstrated in controlled trials to slow the progression of renal failure. ACE inhibitors groups in whom the Hct is kept to 40-42%, to 36% or to 30% respectively. have also been shown to have an effect, especially in diabetic patients [23] .
Valderrábano: In my opinion the management of anaemia is of primary importance. Iron (in some cases Valderrábano: ACE inhibitors are useful in early phases of CRI where it is important to have strict control of intravenous iron) is given before starting EPO which is used in all cases when the haemoglobin level is blood pressure. Cambi: If the target is to correct blood pressure rather <11% (60% of cases). The response to EPO is very good, with 4000 to 6000 units per week, some patients than to stabilize renal function, ACE inhibitors would achieve this, but nothing more.
will reach a Hct of 40% and there is no problem with hypertension in most instances. Bommer: ACE inhibitors are important in the treatment of patients with CRI, not only in the long-term Bommer: I would like to stress that the age of the patient is very important. Whilst in older patients the preservation of kidney function but also in the prevention of vascular complications. Blood pressure reduc-situation is different, in those who are younger, EPO is not usually used during the pre-dialysis period tion in borderline hypertensives with a decreased compliance of the major arteries (e.g. carotid, femoral because they can tolerate a low haemoglobin level (e.g. 9 g/dl ) and if they are treated with iron and are and brachial ) shows that during ACE inhibitor therapy the compliance may normalise, which is not the case generally well nourished they do not experience dangerously low Hct levels. Furthermore, it is difficult to with calcium antagonists. ACE inhibition has other beneficial effects on several complications in these convince them to start dialysis at the optimal time if the anaemia has been corrected too early because they patients [24] [25] [26] . However, in very old patients and diabetics with vascular lesions and a creatinine clear-are feeling much better. Obviously anaemia should not be treated by EPO alone. ance of less than 35-35 ml/min one must be careful. Locatelli: I would like to clarify my previous state-Hoenich: The goals are to try to maintain haemoglobin and Hct at not less than 10 g/dl and 30% respectively ments. The control of blood pressure values at 120/80 mmHg is the first issue and it does not matter for the majority of patients.
Locatelli: It seems clear to me that the importance of so urgent because they comply more readily and can often be kept in a conservative phase much longer, correcting anaemia in pre-dialysis patients is increasingly recognized, although there is a need for controlled provided that their hypertension is controlled.
Valderrábano: The Spanish situation is more or less and randomized trials aimed at evaluating the costbenefit ratio of completely normalising Hct levels. In the same. In fact in general, uraemic patients start dialysis when creatinine clearance is below 12 ml/min this respect the use of iron supplements is of paramount importance before and during the use of EPO, and (in some cases below 15 ml/min) but always on a clinical basis. If the patient has anorexia, nausea, is also in patients not yet in dialysis [31, 32] . markedly acidotic or very hypertensive, conservative treatment should be arrested and dialysis should not Calcium-phosphorus metabolism be delayed. Previously, when we did not realise the importance of nutritional status, we started dialysis at a plasma creatinine of 7 mg%; 6 months later, plasma Locatelli: Let us change gear and discuss the use of vitamin D in patients still on conservative treatment, creatinine had risen to 14 mg%, because muscle wasting had stopped and patients were in an anabolic state. If and ask how early during the course of CRI should one use vitamin D, particularly in relation to plasma the patient is doing well, feels well, is not acidotic and has well controlled blood pressure and anaemia correccalcium and parathyroid hormone levels. Hoenich: There is no UK consensus about the manage-tion, waiting is not a problem and dialysis may be delayed. ment of renal bone disease in the pre-dialysis phase, with specialists disagreeing whether vitamin D and Hoenich: The decision would be based on the clinical well-being of the patient. The majority of patients at 1-alpha vitamin D should be started relatively early. Starting vitamin D, looking at serum PTH levels of the commencement of dialysis would probably still have a residual renal function of between 12 and patients and trying to maintain them at higher levels than in normal subjects is an option.
15 ml/min, however the decision to start dialysis would not be governed by this alone. Bommer: Nearly 50% of the German dialysis population has a 25OH vitamin D serum level below the Bommer: Even though a patient feels better (with EPO and a relatively high haemoglobin level ), it is still normal range or close to the lower limit of normal and need supplementation. 5000-10 000 units of important to start dialysis early enough and provide appropriate artificial kidney replacement of renal funcvitamin D 3 once a week, given during dialysis, is an effective therapy. Compliance with vitamin D 3 therapy tion. We usually start dialysis at a creatinine clearance of 12-15 ml/min and in diabetics even earlier because can be checked by serum 25OH vitamin D measurements. Under such controlled vitamin D therapy a of more frequent fluid overload together with more severe cardiovascular problems and polyneuropathy. target iPTH level of about 200 pgl/ml (three-fold upper limit of healthy controls) can be achieved in most of Locatelli: It is very important to consider residual renal function, since its conservation may prevent a rapid our HD patients. In contrast, the compliance was poor (about 10-20%) in our patients with daily calcitriol increase of plasma b 2 -microglobulin, a well recognized, important factor of morbidity (and possibly mortality) therapy. Locatelli: Dr Bommer, you have discussed the use of in long-term haemodialysis patients [36, 38] . Starting dialysis earlier means decreasing residual renal function vitamin D for the subsequent state, later on during dialysis, and I agree with your statements. In any case more rapidly, except in CAPD. it is clear from your comments that most people agree to administer vitamin D supplementation in preConsensus on pre-dialysis treatments dialysis patients, maintaining plasma PTH at levels higher than in the normal population, to prevent adynamic bone disease. Moreover, hypercalcaemia and Locatelli: To summarize the consensus with respect to the pre-dialysis phase, there was general or majority hyperphosphataemia have been found to be associated with higher cardiac disease and death [33, 34] . These agreement on the following points.
Nutritional aspect: the diet should consist of a protein considerations raise the question as to whether we should change our opinion on optimal plasma PTH, intake of 0.8 g/kg bw/day with an energy intake of no less than 30 and no more than 35 Kcal/kg bw/day. calcium and phosphate levels. Metabolic acidosis: plasma bicarbonate level should be at least 22 mEq/l, using a controlled protein
When to start dialysis diet, calcium carbonate and small doses of sodium bicarbonate.
Hypertension: target blood pressure should be Locatelli: The last topic that I would like to discuss is very important indeed in pre-dialysis care: when to 120/80 mmHg. ACE inhibitors and/or angiotensin II receptor antagonists may be necessary to reach this start dialysis [35] . This aspect has major personal implications for the patients but also relevant organiza-target and may be useful in slowing CRI progression and improving cardiac status. Controlled prospective tional and economic implications for society. Cambi: There is a great difference between young and randomised trials are needed in this field, with blood pressure values at the suggested levels of 120/80 mmHg elderly patients. Amongst the latter, the problem is not 
